Candida Auris: The Emerging Fungal Threat
Candida Auris is an emerging fungal pathogen causing severe infections in healthcare settings worldwide. It was first identified in 2009 in Japan and has since spread to other countries, including the United States, India, South Africa, and several European countries. In this blog post, we will discuss what Candida Auris is, how it spreads, and what it does.
What is Candida Auris?
Candida Auris is a species of Candida, a genus of yeasts commonly found in the human body. Unlike other Candida species, Candida Auris can cause severe infections that are difficult to treat. It is often resistant to multiple antifungal drugs, which makes it a significant threat to public health.
How does Candida Auris spread?
Candida Auris is a species of Candida, a genus of yeasts commonly found in the human body. Unlike other Candida species, Candida Auris can cause severe infections that are difficult to treat. It is often resistant to multiple antifungal drugs, which makes it a significant threat to public health.
What does Candida Auris do?
Candida Auris can cause various infections, including bloodstream infections, wound infections, and ear infections. The symptoms of Candida Auris infections can vary depending on the type of infection and the patient’s overall health. Some patients may not show signs, while others may experience fever, chills, and sepsis.
Why is Candida Auris a concern?
Candida Auris is a significant concern for several reasons. First, it is resistant to multiple antifungal drugs, which makes it challenging to treat. Second, it is often misidentified in laboratories, which can lead to delays in diagnosis and treatment. Finally, it has a high mortality rate, with some studies reporting mortality rates as high as 60%.
Conclusion:
Candida Auris is an emerging fungal pathogen that poses a significant threat to public health. It is often resistant to multiple antifungal drugs and can cause severe infections that are difficult to treat. Healthcare facilities must take proper infection control measures to prevent the spread of Candida Auris and ensure prompt diagnosis and treatment of infections. As the world continues to face new and emerging infectious diseases, it is essential to remain vigilant and work together to combat these threats.
Sources:
Centers for Disease Control and Prevention. Candida auris. Retrieved from https://www.cdc.gov/fungal/candida-auris/index.html
Chowdhary, A., Prakash, A., Sharma, C., & Kordalewska, M. (2020). Candida auris: A rapidly emerging cause of hospital-acquired multidrug-resistant fungal infections globally. PLoS Pathogens, 16(1), e1009190. https://doi.org/10.1371/journal.ppat.1009190
Jeffery-Smith, A., Taori, S. K., Schelenz, S., Jeffery, K., Johnson, E. M., Borman, A.,… & Brown, C. S. (2018). Candida auris: A review of the literature. Clinical Microbiology Reviews, 31(1), e00029-17. https://doi.org/10.1128/CMR.00029-17
60 Minutes Segment Addesses Indoor Air Crisis
Dinesh Wadhwani To Speak at ISSA Conference
© 2023 — ThinkLite. All Right Reserved.